Search research articles
Contact Us
Filters
Showing results (301-310 of 706) with videos related to
Page
of 71
Sort By:
JACC. Cardiovascular Interventions
|
November 20, 2010
Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines)
Mitul B Kadakia, Nihar R Desai, Karen P Alexander, et al.
Journal of the American Heart Association
|
June 12, 2016
Relationship Between Low-Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid-Lowering Strategies
Jacques Rey, Franck Poitiers, Tobias Paehler, et al.
Archives of Internal Medicine
|
August 12, 2009
The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes
Tracy Y Wang, Gregg C Fonarow, Adrian F Hernandez, et al.
Diabetes, Obesity & Metabolism
|
February 27, 2023
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study
Suzanne V Arnold, James A de Lemos, Luke Zheng, et al.
Journal of Hypertension
|
June 12, 2009
Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study
Henry Krum, Gary Swergold, Sean P Curtis, et al.
Journal of the American Heart Association
|
May 3, 2014
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome
Amy Sarma, Christopher P Cannon, James de Lemos, et al.
JAMA Cardiology
|
July 18, 2019
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial
Richard G Bach, Christopher P Cannon, Robert P Giugliano, et al.
European Heart Journal
|
August 5, 2006
Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS
Kausik K Ray, Richard G Bach, Christopher P Cannon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 29, 2020
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Giuseppe Gargiulo, Christopher P Cannon, Charles Michael Gibson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 26, 2023
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV
Samuel Dagogo-Jack, Robert Frederich, Jie Liu, et al.
Page
of 71
Search research articles
Search
Showing results (301-310 of 706) with videos related to
Sort By:
Page
of 71
JACC. Cardiovascular Interventions
|
November 20, 2010
Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines)
Mitul B Kadakia, Nihar R Desai, Karen P Alexander, et al.
Journal of the American Heart Association
|
June 12, 2016
Relationship Between Low-Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid-Lowering Strategies
Jacques Rey, Franck Poitiers, Tobias Paehler, et al.
Archives of Internal Medicine
|
August 12, 2009
The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes
Tracy Y Wang, Gregg C Fonarow, Adrian F Hernandez, et al.
Diabetes, Obesity & Metabolism
|
February 27, 2023
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study
Suzanne V Arnold, James A de Lemos, Luke Zheng, et al.
Journal of Hypertension
|
June 12, 2009
Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study
Henry Krum, Gary Swergold, Sean P Curtis, et al.
Journal of the American Heart Association
|
May 3, 2014
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome
Amy Sarma, Christopher P Cannon, James de Lemos, et al.
JAMA Cardiology
|
July 18, 2019
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial
Richard G Bach, Christopher P Cannon, Robert P Giugliano, et al.
European Heart Journal
|
August 5, 2006
Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS
Kausik K Ray, Richard G Bach, Christopher P Cannon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
October 29, 2020
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Giuseppe Gargiulo, Christopher P Cannon, Charles Michael Gibson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 26, 2023
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV
Samuel Dagogo-Jack, Robert Frederich, Jie Liu, et al.
Page
of 71